April 9, 2016 eClinik

The United States government has a patent on cannabinoids as anti-oxidant for auto-immune diseases, and as neuroprotectants for treatment of Alzheimer’s disease, Parkinson’s disease, and HIV dementia.

Ironically, government policies are not in sync with realities on the ground and with its own scientific discoveries. This only proves that government is indeed not in control of itself.

From US Patent 6630507 B1’s abstract,

“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.”

SNIP